Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
CBIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.87%285.761.5%$877.84m
GILDGilead Sciences, Inc. -0.19%87.791.0%$684.30m
MRNAModerna, Inc. 3.15%179.000.0%$651.73m
REGNRegeneron Pharmaceuticals, Inc. 2.25%764.272.6%$499.64m
VRTXVertex Pharmaceuticals, Inc. 1.85%317.581.9%$473.10m
BIIBBiogen, Inc. 0.23%292.151.8%$407.81m
ILMNIllumina, Inc. 1.23%208.523.2%$225.94m
BMRNBioMarin Pharmaceutical, Inc. 1.44%103.694.2%$162.19m
BNTXBioNTech SE 0.63%162.630.0%$150.70m
AXSMAxsome Therapeutics, Inc. 3.85%78.161.6%$146.95m
SNSSSunesis Pharmaceuticals, Inc. -3.98%1.930.7%$134.91m
RXDXPrometheus Biosciences, Inc 165.67%95.801.4%$103.84m
MRTXMirati Therapeutics, Inc. -30.66%49.591.6%$102.08m
HALOHalozyme Therapeutics, Inc. 2.41%57.7418.4%$82.03m
NVAXNovavax, Inc. 2.62%17.2275.3%$81.88m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.